The human embryonic stem cell line RCe006-A (RC-2) was derived from a frozen and thawed blastocyst voluntarily donated as surplus to fertility requirements following ethics committee approved informed consent under licence from the UK Human Fertilisation and Embryology Authority. The cell line exhibits expression of expected pluripotency markers and in vitro differentiation potential to three germinal lineage representative cell populations. It has a male trisomy 12 karyotype (47XY, +12). Microsatellite DNA marker identity and HLA and blood group typing data are available.
The human embryonic stem cell line RCe006-A (RC-2) was derived from a frozen and thawed blastocyst voluntarily donated as surplus to fertility requirements following ethics committee approved informed consent under licence from the UK Human Fertilisation and Embryology Authority. The cell line exhibits expression of expected pluripotency markers and in vitro differentiation potential to three germinal lineage representative cell populations. It has a male trisomy 12 karyotype (47XY, +12 
Resource details
RCe006-A (RC-2) was derived from a frozen and thawed, surplus to requirement, blastocyst. The cell line was derived by whole embryo outgrowth on mitotically inactivated human dermal fibroblast (HDF) feeder cells using HDF conditioned medium and expanded under feeder free conditions. RCe006-A (RC-2) was shown to be pluripotent by expression of the pluripotency markers Oct4, Nanog Tra-1-60 and Tra-1-81, but not the differentiation marker SSEA-1 using immunocytochemistry (Table 1, Fig. 1 ). By flow cytometric analysis, expression of the pluripotency makers SSEA-4, Tra-1-60 and Tra-1-81 was 81.8%, 55.0% and 43.6%, respectively, whereas low expression of the differentiation marker SSEA-1 (2.3%), was observed at passage 6 (Fig. 2) . Differentiation to the three germ layers, endoderm, ectoderm and mesoderm, was demonstrated using embryoid body formation with all three germ layers present as shown by expression of α-fetoprotein, β-tubulin and muscle actin (Fig. 3) .
A microsatellite PCR profile has been obtained for the cell line, and HLA Class I and II typing is available (Table 2 ). Blood group genotyping gave the blood group BO 1 (Table 2) .
Verification and authentication
The cell line was analysed for genome stability by G-banding ( 
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Materials and methods

Ethics
Derivation of hESC from surplus to requirement and failed to fertilise/develop embryos was approved by The Scotland A Research Ethics Committee and local ethics board at participating fertility clinics and conducted under licence no R0136 from the UK HFEA with informed donor consent.
Cell culture
Frozen embryos were thawed using Embryo Thawing Pack (Origio (Medicult), Denmark) using standard techniques and were cultured EmbryoAssist (Origio) until Day 3 or BlastAssist (Origio) after Day 3 of development. Embryos were cultured at 36.5-37.5°C, 5 ± 0.5% CO 2 , 5 ± 0.5% O 2 in drops under paraffin oil (Origio) and transferred to fresh medium at least every 2-3 days.
By Day 8 of development, or when spontaneous hatching occurred, embryos were placed in derivation conditions consisting of mitotically inactivated neonatal human dermal fibroblasts (HDFs) (ThermoFisher Scientific (Cascade Biologics), Paisley, UK) on tissue culture plastic precoated with 2 μg/cm 2 human laminin (Sigma-Aldrich, Dorset, UK) as per manufacturer's recommendation. If required, assisted hatching was performed by removing the zona pellucidae mechanically using Swemed cutting tools (Vitrolife, Göteborg, Sweden). HDF cells were cultured in DMEM (Lonza, Slough, UK), 10% FCS (GE Healthcare (PAA), Buckinghamshire, UK) and 2 mM L-glutamine (ThermoFisher Scientific). HDFs were mitotically inactivated using gamma irradiation at 50 Gy using a Gammacell Elite 1000 machine. For use as a feeder layer, irradiated HDFs were plated at 2-50,000 cells/cm 2 in HDF conditioned medium (80% Knockout-DMEM, 20% Knockout serum replacement (KOSR), 1 mM glutamine, 0.1 mM β-mercaptoethanol, 1% nonessential amino acids, and 4 ng/ml human bFGF (all ThermoFisher Scientific) over 24 h intervals over 7 days) supplemented with an additional 24 ng/ml human bFGF. Cells Embryoid body formation To show differentiation to three germ layers Expression of muscle actin, β-tubulin and α-feto protein Fig. 1 . Immunostaining of RCe006-A (RC-2) show expression of the pluripotency markers Oct-4 (red), Nanog, Tra-1-60, Tra-1-81 (green), but not the differentiation marker SSEA-1 (green). Cell nuclei are counterstained with DAPI (blue).
Fig. 2.
RCe006-A (RC-2) (passage 6) was subjected to flow cytometry analysis for markers of pluripotency with specific antibody or isotype control as indicated above the histograms. Percentage staining is indicated in Table 1 . were cultured at 36.5-37.5°C, 5 ± 0.5% CO 2 , 5 ± 0.5% O 2 and 50% medium exchanged 6 days a week. The established cell line was expanded and banked using CellStart matrix and Stempro hESC Serum Free Medium (ThermoFisher Scientific). Passaging was performed mechanically using an EZ passage tool (ThermoFisher Scientific). hESC lines were expanded to 25-30 wells of a 6-well plate and cryopreserved in 0.5-1 ml KOSR based cryopreservation solution (75% KO-DMEM, 15% Xeno-free KOSR (ThermoFisher Scientific) and 10% DMSO (Origen Biomedical, Texas, USA)) or Cryostor CS10 (Biolife Solution, Washington, USA).
Mycoplasma
Mycoplasma detection was performed using Applied Biosystems PrepSEQ™ Mycoplasma Nucleic Acid Extraction Kit and MicroSEQ™ Mycoplasma Real-Time PCR Detection Kit (ThermoFisher Scientific (Applied Biosystems, ThermoFisher Scientific) according to the manufacturer's instruction.
Endotoxin
Endotoxin levels were determined using the Kinetic-QCL assay (Lonza) and an incubating plate reader (BioTek ELx808) according to the manufacturer's instructions. Briefly, an unknown sample was compared with a standard curve of known levels of control endotoxin. An assay was deemed valid if the coefficient of correlation, r ≥ 0.980 and the CV (%) for the standard curve was ≤10%.
Flow cytometry
Human embryonic stem cells were dissociated using Trypsin (ThermoFisher Scientific). Non-specific staining was blocked using 5% goat serum (Sigma) in PBS (Lonza) containing 0.01% Tween-20 (Sigma). Cells were stained with antibodies against SSEA-4, SSEA-1, Tra-1-60 and Tra-1-81 (all BD, Oxford, UK), at 250 ng per reaction followed by Goat F(ab)2 anti-mouse IgM-PE Goat F(ab)2 anti-mouse IgG3-FITC (1:200; Santa Cruz Biotechnology, Texas, USA). Cells were analysed using a FACS Aria flow cytometer (BD).
Immunocytochemistry hESCs were fixed in 4% paraformaldehyde (ThermoFisher Scientific (Alfa Aesar)), permeabilised using 100% ethanol (ThermoFisher Scientific) and stained with AFP (1:500; Sigma), β-tubulin III (1:1000; Sigma), muscle-specific actin (1:50; DAKO, Glostrup, Denmark), Oct-4 (1:200; Santa Cruz Biotechnology), Nanog (1:20; R&D Systems, Abingdon, UK), Tra-1-60, Tra-1-81, SSEA-1 (all 1:50; BD) and secondary antibodies anti-mouse IgG-FITC (1:200; Sigma), anti-mouse IgG-AlexaFluor 488, anti-goat IgG-AlexaFluor 488, antigoat IgG-AlexaFluor-594, anti-donkey polyclonal AlexaFluor-594 (all 1:200; ThermoFisher Scientific). Images were acquired using a Zeiss S100 Axiovert fluorescence microscope or Nikon eC1 confocal microscope.
In vitro differentiation
hESC cells were pre-treated for 1 h with 10 μM ROCK inhibitor in Stempro hESC SFM (ThermoFisher Scientific) and embryoid bodies EBs generated in ultra low attachment plates (Corning) for 7 days before being transferred into EB medium (20% FBS (GE Healthcare (PAA)), 80% KO-DMEM 1 mM L-glutamine, 0.1 mM β-mercaptoethanol, 1% nonessential amino acids (all ThermoFisher Scientific)), on glass slide tissue culture chambers (Nunc, ThermoFisher Scientific) coated with 0.5% gelatin (Sigma) at 0.1 ml/cm 2 for 14 days.
Genomic analysis
All outsourced assays were carried out under a Quality and Technical Agreement. DNA was extracted using the QIAamp DNA Mini kit (Qiagen, Manchester, UK) according to the manufacturer's recommendations and provided in recommended quantities to the service providers.
Microsatellite PCR, or Short Tandem Repeat analysis, was used to determine cell line identity and was carried out by Public Health England. A profile was obtained for the following core alleles: vWA, D16S539, Amelogenin, THO1, CSF1PO, D5S818, D75820, D135317 and TPOX.
Human Leukocyte Antigen (HLA) tissue typing was carried out by the Scottish National Blood Transfusion Service.
Blood group genotyping was carried out by the Molecular Diagnostics Laboratory at NHSBT.
Karyotype analysis was carried out by The Doctors Laboratory (London, UK) or the Western General Cytogenetics Laboratory (Edinburgh, UK). Live cells at 60-70% confluency were shipped overnight in warm containers, fixed and analysed by standard G-banding analysis. For research grade lines, 20 spreads were analysed.
